Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGCETACOPLAN vs PEGFILGRASTIM-CBQV: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

PEGCETACOPLAN vs PEGFILGRASTIM-CBQV: Safety Overview

Metric PEGCETACOPLAN PEGFILGRASTIM-CBQV
Total FAERS Reports 1,369 732
Deaths Reported 84 104
Death Rate 6.1% 14.2%
Hospitalizations 252 94
Average Patient Age 65.4 yrs 55.2 yrs
% Female Patients 70.5% 60.3%
FDA Approval Date Feb 17, 2023 N/A
Manufacturer Apellis Pharmaceuticals, Inc. N/A
Route SUBCUTANEOUS N/A
Marketing Status Prescription Prescription